Key takeaways
Insurance coverage for GLP-1s can vary by plan.
When a GLP-1 is covered by insurance, prior authorization is usually required.
If coverage is denied, you may still be able to get GLP-1s at a lower cost with cash-pay options (such as those on Ro) and manufacturer savings programs.
Here's what we'll cover
Key takeaways
Insurance coverage for GLP-1s can vary by plan.
When a GLP-1 is covered by insurance, prior authorization is usually required.
If coverage is denied, you may still be able to get GLP-1s at a lower cost with cash-pay options (such as those on Ro) and manufacturer savings programs.
To get a GLP-1 medication with insurance, you’ll want to review your plan’s list of covered medications and have your healthcare provider submit prior authorization paperwork on your behalf. The process can require some back and forth with your insurance company.
That's why we wrote this article: to make the insurance process easier to navigate. If you're ready to start treatment with GLP-1 medication such as Wegovy (semaglutide) or Zepbound (tirzepatide) for weight loss, read on.
How to get insurance coverage for GLP-1 medications
Getting your insurance plan to cover your GLP-1 sometimes requires a bit more legwork than other medications, but the process essentially boils down to four steps:
1. Review your plan’s list of covered medications, aka formulary (or use Ro’s GLP-1 Insurance Checker)
2. Get a prescription from a licensed healthcare provider
3. Submit a prior authorization request
4. Get approved, appeal, or request an exception
1. Review your plan's formulary and coverage criteria
Your plan’s formulary is a list of all the medications that are covered by your plan. You can usually find it on your insurance provider’s website or patient portal.
If the formulary lists a GLP-1, that means it's covered under your specific plan, though you may need to meet certain coverage requirements. If a GLP-1 isn't listed, that means it isn't covered by your plan. However, know that insurance plans can change their coverage of GLP-1s at any time, so it's worth calling your insurance plan directly to confirm the medication is still covered.
If a medication is covered, the formulary will tell you its:
Cost tier. GLP-1s typically have higher co-pays. If you have a deductible on your commercial insurance plan, you may have to pay more for the medication until you meet it. After that, your plan’s usual copay or coinsurance may apply.
Covered conditions. Generally, insurance plans are more likely to cover a medication for its FDA-approved condition. So, your insurance plan may cover Wegovy, Zepbound, or Saxenda (liraglutide) for chronic weight management — but not Ozempic (semaglutide) or Mounjaro (tirzepatide), which are approved for diabetes and not specifically for weight loss.
Coverage requirements. Some insurance plans require step therapy and/or prior authorization before they’ll cover a GLP-1. We’ll review these in the next step.
Not sure if your plan covers your GLP-1? Depending on the medication, you can find out using Ro’s free GLP-1 Insurance Coverage Checker.
2. Get a prescription from a healthcare provider
Now that you know which GLP-1 medications are covered by your plan, you’ll need to meet with a healthcare provider to get a prescription (that is, of course, as long as the provider thinks GLP-1 treatment is a fit).
You can do so in person by meeting with a provider, such as your primary care physician, or online via a telehealth platform like Ro.
If you opt for the virtual route with Ro’s weight loss program, your first step is to answer a few questions about your health history and weight loss goals. From there, a licensed healthcare provider affiliated with Ro will review your responses and determine whether you’re a good fit for GLP-1 treatment within a few days. Sometimes, they may order a metabolic lab test (included in your membership cost) to better understand your hormone and metabolic health or to support insurance coverage.
If eligible, your Ro-affiliated provider will then write you a prescription for the specific GLP-1 medication. And as a Ro Body member, you can tap Ro’s insurance concierge for help with figuring out and securing insurance coverage.
When you meet with a provider in person, you will likely be asked similar questions to those in Ro’s online visit.
During your appointment, your provider will inquire about your personal and family medical history. Some pre-existing health conditions make some GLP-1 medications unsafe or require extra caution. For example, several GLP-1–based medications should not be used if you or a family member has had medullary thyroid carcinoma (MTC) or if you have multiple endocrine neoplasia syndrome type 2 (MEN2).By sharing your full medical history with your provider (in person or virtually, for that matter), you can help them determine which medication is safe for you.
Be sure to tell them about any medications you are taking, including prescription medications, over-the-counter (OTC) supplements, and vitamins. GLP-1 medications work by delaying gastric emptying, which can affect your body’s absorption of oral medications.
Also, share your experience with losing weight through other methods. Understanding how your body has responded to different eating plans, exercise, or other medications can help your provider determine whether a GLP-1 such as Wegovy or Zepbound is a good choice for you or if another weight loss medication or intervention could be more effective.
"This [information] will help our providers advocate for them and demonstrate to the insurance provider that a patient has tried many different types of medications, diets, and exercise plans and they have not worked," says Raoul Manalac, MD, a board-certified internal medicine physician and Senior Director of Obesity Medicine at Ro.
3. Submit prior authorization (PA)
Most insurance plans, including Medicare, require prior authorization (PA) before they will cover a GLP-1 medication. PA is paperwork your healthcare provider submits on your behalf stating that you meet your insurance plan’s coverage criteria for a GLP-1. When taking a GLP-1 for weight loss, this may include:
Your body weight/BMI. GLP-1s are approved for weight loss in people with obesity or with overweight and a weight-related medical condition, such as high cholesterol or type 2 diabetes. You can check where you fall using a body mass index (BMI) calculator, though your healthcare provider will weigh other health factors beyond this number alone.
Step therapy. Some plans require you to try a less expensive medication or an eating and exercise program first before they'll cover a GLP-1 for weight loss. While the specific timeline can vary by plan, generally, some may require documentation that you participated in a lifestyle program or tried another treatment first.
A commitment to making lifestyle changes. Specifically, your plan may want confirmation that your treatment plan includes not only taking the GLP-1 medication, but taking it in combination with the recommended lifestyle changes (i.e. a reduced-calorie eating plan and increased physical activity).
Once your healthcare provider submits the form, it can take up to 15 days for your insurance company to review it and issue a response. Medicare Part D generally requires a decision on a standard drug coverage request within 72 hours. Prior authorization decisions through the Medicare GLP-1 Bridge are also generally communicated within 72 hours.
Ro Body members can access Ro’s insurance concierge for help navigating all things insurance coverage. If a Ro-affiliated provider writes you an Rx, the concierge will coordinate with your insurance to help get medication costs covered.
In other words, they do all of the heavy lifting: communicating directly with your insurance provider, submitting paperwork for PA, and even exploring cost-saving options — all on your behalf and at no additional charge. The process takes 1–3 weeks, and when coverage is determined, they’ll send your script to your preferred pharmacy to be filled.
4. Respond to your insurance company's decision
If your insurance plan approves your prior authorization request, you’re good to go!
If your plan didn’t approve your request, don’t lose hope just yet. Read carefully to understand the reason why (they have to give you one). It’s possible that the paperwork was incomplete, and they’re simply asking for more information. In this scenario, your healthcare provider can resubmit the prior authorization with the requested information.
If they denied coverage outright, you can appeal their denial or request an exception. In this scenario, your healthcare provider may need to submit a letter of medical necessity explaining why it is medically necessary and why covered alternatives may not be appropriate for you.
If your insurance plan still denies coverage, you may need to go back to the drawing board with your healthcare provider. Talk to them about your other GLP-1 treatment options, if there are any that are covered by your plan.
If your plan only covers traditional weight loss pills, you can also ask your provider if they may be a good alternative. While they’re typically less effective than GLP-1s for weight loss, they can be less expensive out-of-pocket.
What if I am denied insurance coverage for GLP-1s?
If you are denied insurance coverage for GLP-1s, there are still ways you can save on the medication.
Just because insurance may not cover your treatment doesn't mean the road ends there — you can still get your Rx (if appropriate) at a fraction of the list price on Ro.
If you haven't already, you'll first need to complete an online visit, which will then be reviewed by a Ro-affiliated healthcare provider. If your provider determines a GLP-1 medication is a fit, they'll write you a prescription, and you can simply opt to pay cash. Depending on the medication prescribed, your medication may cost just $149 per month.
Here are the cash-pay prices for GLP-1s on Ro (if prescribed)*:
Wegovy pill: $149–$299 per month, depending on the dose
Wegovy pen: $199–$399 per month, depending on the dose
Zepbound KwikPen: $299-$449 per month, depending on the dose
Foundayo: $149–$299 per month, depending on the dose
Manufacturer savings cards are also worth a look — though for GLP-1s already available through cash-pay on Ro, like Wegovy, Zepbound, and Foundayo, these cards typically bring the uninsured price to about the same range you'd already get on Ro. They're more likely to make a real difference for medications not currently available for cash-pay on Ro, like Mounjaro and Ozempic, or if you have some insurance coverage that just doesn't include your GLP-1 — in that case, a card can sometimes bring your cost down to as low as $25 per month. The one exception is Medicare, Medicaid, and other government-funded insurance plans, which aren't eligible for these savings offers.
Here's a quick look at the price of GLP-1s with manufacturer savings cards:
Foundayo: As low as $25 per month (with coverage); $149–$299 per month (without coverage)
Mounjaro: As low as $25 per month (with coverage); as low as $499 per month (without coverage)
Ozempic pill: As low as $25 per month (with coverage); $149–$299 per month (without coverage)
Ozempic pen: As low as $25 per month (with coverage); $199–$499 per month (without coverage)
Wegovy pill: As low as $25 per month (with coverage); $149–$299 per month (without coverage)
Wegovy pen: As low as $25 per month (with coverage); $199–$399 per month (without coverage)
Zepbound: As low as $25 per month (with coverage); $299–$499 per month (without coverage)
The savings card program for Saxenda has been discontinued.
Next, price-shop local pharmacies. Prices can vary from pharmacy to pharmacy, and some may have promotions or coupons that lower the price of the medication. Also, check online pharmacies, which may include free shipping to your home.
If you can afford it, sometimes purchasing a two- or three-month medication refill can be more cost-effective over the long run than a one-month refill.
Finally, if you choose to fill at your pharmacy, you may still be able to save using a pharmacy discount card. These are available for free from websites like GoodRx, SingleCare, and OptumPerks. You just need to select your GLP-1, dose, and preferred pharmacy to download or print your coupon.
*Pricing may reflect limited-time and/or manufacturer offers. Terms and conditions may apply for certain doses; see more here.
Bottom line
Insurance coverage isn't always guaranteed for GLP-1s. Plans can choose which medications to include in their formularies.
You can find out if your insurance covers GLP-1s by reviewing your formulary online or calling the number on the back of your insurance card.
If you have an insurance plan that does cover a GLP-1, your healthcare provider will likely need to submit prior authorization on your behalf.
If your insurance plan denies coverage, you can work with your healthcare provider to appeal their decision.
Other ways to save on GLP-1s include manufacturer savings offers, self-pay options, and pharmacy coupons.
Frequently asked questions (FAQs)
Where can I get GLP-1 covered by insurance?
Insurance plans can choose which medications they cover. To check if your insurance plan covers GLP-1s, review your medication formulary online, call the number on the back of your insurance card, or use Ro's free GLP-1 insurance checker, depending on the specific GLP-1.
Is CVS no longer covering Zepbound?
While CVS had previously dropped Zepbound from their prescription medication coverage, CVS Caremark is adding it back as a preferred option on its common commercial formularies starting October 1, 2026. However, individual employers and health plans can customize their formularies, so coverage will still vary by plan.
Why won't my insurance cover Zepbound?
Insurance plans can choose which medications they cover, and not all plans cover Zepbound. Some plans will not cover medications for weight loss, such as Zepbound. If your plan does cover Zepbound but denied your coverage request, they are required by law to give you an explanation why. You can also appeal their coverage denial.
How do I get my insurance to approve GLP-1 medication?
To get your insurance to approve GLP-1 medication, you'll need to get a prescription for an FDA-approved condition (e.g. Wegovy for weight loss, Ozempic for type 2 diabetes). Then, your healthcare provider will need to submit prior authorization showing that the GLP-1 is a medically necessary treatment for you. That said, some plans don't cover GLP-1s at all.
What are GLP-1 medications?
Glucagon-like peptide-1 (GLP-1) medications are prescribed for weight loss, type 2 diabetes, and related conditions. These medications work by mimicking GLP-1, a gut hormone produced naturally by your body that helps manage blood sugar levels and regulate your appetite. Some GLP-1 medications include:
Ozempic (semaglutide)
Wegovy (semaglutide)
Saxenda (liraglutide)
Foundayo (orforglipron)
Dual GIP/GLP-1 medications activate receptors for both GLP-1 and another hormone called glucose-dependent insulinotropic polypeptide (GIP). This dual action can help regulate blood sugar and support weight loss. GLP-1/GIP medications include:
Mounjaro (tirzepatide)
Zepbound (tirzepatide)
How much do drugs like Wegovy, Ozempic cost?
Without insurance, the average cost of medications such as Ozempic and Wegovy can range from $1,000 to over $1,300. When prescribed and purchased using self-pay on Ro, the prices drop to $149–$499 per month*, depending on the medication and dose. The price you'll pay for GLP-1s depends on your insurance coverage, the condition you are using the medication to treat, and the pharmacy you use.
If you have a valid prescription and commercial or private insurance, you may be eligible for a GLP-1 savings offer from the manufacturer, which can bring down the monthly cost to as low as $25. Novo Nordisk also offers a patient assistance program (PAP) which helps cover the cost of Ozempic for people who meet certain eligibility requirements.
*Pricing may reflect limited-time and/or manufacturer offers. Terms and conditions may apply for certain doses; see more here.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
Ozempic Important Safety Information: Read more about serious warnings and safety info.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
Saxenda Important Safety Information: Read more about serious warnings and safety info.
Mounjaro Important Safety Information: Read more about serious warnings and safety info.
Foundayo Important Safety Information: Read more about serious warnings and safety info.
References
Collins, L. & Costello, R. A. (2024). Glucagon-like Peptide-1 Receptor Agonists. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK551568/
Centers for Medicare & Medicaid Services (CMS). (2026). Information for Providers: Medicare GLP-1 Bridge. Retrieved Sep. 11, 2026 from https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-providers
CVS Health. (2026). CVS Caremark delivers affordability and access to GLP-1 weight management medications with expanded coverage options. Retrieved from https://www.cvshealth.com/news/company-news/cvs-caremark-delivers-affordability-and-access-to-glp-1-weight-management-medications-with-expanded-coverage-options.html
Eli Lilly-a. (2026). Coverage & Savings for Foundayo (orforglipron). Retrieved from https://foundayo.lilly.com/coverage-savings
Eli Lilly-b. (2026). Savings & Support. Retrieved from https://mounjaro.lilly.com/savings-coverage
Eli Lilly-c. (2026). Terms and Conditions for the Zepbound Single-Dose Pen and Single-Patient-Use KwikPen Savings Card Program. Retrieved from https://zepbound.lilly.com/savings/terms-and-conditions
Employee Benefits Security Administration. (n.d.). Filing a Claim for Your Health Benefits. US Department of Labor. Retrieved from https://www.dol.gov/agencies/ebsa/about-ebsa/our-activities/resource-center/publications/filing-a-claim-for-your-health-benefits
Goldberg, R. B. (2020). Managing the pharmacy benefit: the formulary system. Journal of Managed Care & Specialty Pharmacy, 26(4), 341–349. doi: 10.18553/jmcp.2020.26.4.341a. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10391211/
Griauzde, D. H., Carter, E. W., Oshman, L., et al. (2025). Understanding insurance coverage policies for incretin mimetics for weight management. The American Journal of Managed Care, 31(7), 342–349. doi: 10.37765/ajmc.2025.89685. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12710463/
Hwang, J. H., Laiteerapong, N., Huang, E. S., & Kim, D. D. (2025). Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults. JAMA Health Forum, 6(3), e245586. doi: 10.1001/jamahealthforum.2024.5586. Retrieved from https://jamanetwork.com/journals/jama-health-forum/fullarticle/2831205
Liu, X., Lu, C. A., Shih, Y. T., et al. (2025). Coverage and prior authorization policies for semaglutide and tirzepatide in Medicare Part D plans. JAMA Network Open, 8(8), e2529842. doi: 10.1001/jamanetworkopen.2025.29842. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12397888/
Luo, J., Feldman, R., Rothenberger, S. D., et al. (2020). Coverage, formulary restrictions, and Out-of-Pocket costs for Sodium-Glucose cotransporter 2 inhibitors and Glucagon-Like peptide 1 receptor agonists in the Medicare Part D program. JAMA Network Open, 3(10), e2020969. doi: 10.1001/jamanetworkopen.2020.20969. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7563069/
Novo Nordisk-a. (2026). Discover ways to save on Wegovy. Retrieved from https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html
Novo Nordisk-b. (2026). Find out the cost for Ozempic. Retrieved from https://www.novocare.com/diabetes/products/ozempic/explaining-list-price.html
Novo Nordisk-c. (2026). Ozempic (semaglutide) Cost and Insurance Coverage. Retrieved from https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
Novo Nordisk-d. (2026). Patient Assistance Program. Retrieved from https://www.novocare.com/diabetes/help-with-costs/pap.html
Novo Nordisk-e. (2026). Wegovy. Retrieved from https://www.novopricing.com/wegovy.html
Pearson, S. D., Whaley, C. M., & Emond, S. K. (2025). Affordable access to GLP-1 obesity medications: strategies to guide market action and policy solutions in the US. Journal of Comparative Effectiveness Research, 14(9), e250083. doi: 10.57264/cer-2025-0083. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12403326/
Tchang, B. G., Aras, M., Kumar, R. B., et al. (2024). Pharmacologic treatment of overweight and obesity in adults. Endotext. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK279038/
US Centers for Medicare & Medicaid Services. (2024). Has Your Health Insurer Denied Payment for a Medical Service? You Have a Right to Appeal. Retrieved from https://www.cms.gov/cciio/resources/fact-sheets-and-faqs/appeals06152012a















